Repligen Corp. RGEN

NAS: RGEN | ISIN: US7599161095 30/04/2025

137,99 USD (-1,03%)

(-1,03%) 30/04/2025

Grafiek Repligen Corp.

Grafiek Repligen Corp.

1 dag1d -1,03%
1 week1w -4,99%
1 maand1m 7,39%
3 maanden3m -13,69%
6 maanden6m -0,45%
1 jaar1j -12,86%
5 jaar5j 22,21%

Repligen Corp. in het nieuws

Toon enkel gratis nieuws

9 september 2021 · Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies · Persbericht

17 maart 2021 · Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum · Persbericht

3 maart 2021 · Repligen Corporation to Present at Barclays Global Healthcare Conference · Persbericht

24 februari 2021 · Repligen Reports Fourth Quarter and Full Year 2020 Financial Results · Persbericht

22 februari 2021 · Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Conference · Persbericht

11 februari 2021 · Repligen to Report Fourth Quarter and Full Year 2020 Financial Results · Persbericht

8 februari 2021 · Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines · Persbericht

4 januari 2021 · Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Profiel Repligen Corp.

Gezondheidstechnologie

Productie van biologische producten

Website: www.repligen.com

Hoofdzetel: Waltham, Massachusetts Verenigde Staten

CEO: Anthony Hunt

Werknemers: 1.007

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe